{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:31:10Z","timestamp":1792506670290,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T00:00:00Z","timestamp":1155081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe the content and potentials of the new Swedish national register on prescribed and dispensed medicines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Swedish Prescribed Drug Register contains information about age, sex and unique identifier of the patient as well as the prescriber's profession and practice. Information regarding drug utilization and expenditures for prescribed drugs in the entire Swedish population was extracted from the first six months July\u2013December 2005 and compared with total drug sales in the country including OTC and hospital use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The total quantity of drugs sold in Sweden was 2666 million DDDs, corresponding to 1608 DDD\/1000 inhabitants daily. The total expenditures were 1.6 billion Euro. The prescribed drugs, included in the register, accounted for 84% of the total utilization and 77% of the total expenditures. About half of all men and two\u2010thirds of all women in the country purchased drugs. The proportion increased by age. The most common drugs for chronic treatment were diuretics among women (8.8% of the population) and antithrombotic agents among men (7.6%). Psychotropic drugs, corticosteroids and analgesics were more common among women, while men used antithrombotic agents, antidiabetic drugs, lipid lowering agents and ACE inhibitors to a greater extent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The new register provides valuable data on exposure to drugs and is useful to study patterns of drug utilization. The possibilities for record linkage to other health registers gives from an international perspective good opportunities to explore drug and disease associations and the risks, benefits, effectiveness and health economical effects of drug use. Copyright \u00a9 2006 John Wiley &amp; Sons, Ltd.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.1294","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T07:07:05Z","timestamp":1155107225000},"page":"726-735","source":"Crossref","is-referenced-by-count":1648,"title":["The new Swedish Prescribed Drug Register\u2014Opportunities for pharmacoepidemiological research and experience from the first six months"],"prefix":"10.1002","volume":"16","author":[{"given":"Bj\u00f6rn","family":"Wettermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Hammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"MichaelFored","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrejs","family":"Leimanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Otterblad Olausson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Westerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5ns","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,8,9]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Pharmacoepidemiology","author":"Strom B","year":"2005"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90092-2"},{"key":"e_1_2_1_4_2","volume-title":"Psychiatry. V World Congress of Psychiatry, Mexico","author":"Bergstr\u00f6m K","year":"1971"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561402"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90101-9"},{"key":"e_1_2_1_7_2","first-page":"31","article-title":"Pharmacoepidemiology\u2014from description to quality assessment. A Swedish perspective","volume":"11","author":"Bergman U","year":"2001","journal-title":"Norwegian Journal of Epidemiology"},{"key":"e_1_2_1_8_2","volume-title":"Monitoring public health and social conditions in Sweden 1992\u20132002","author":"National Board of Health and Welfare","year":"2003"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(94)90050-7"},{"key":"e_1_2_1_10_2","unstructured":"World Health Organization (WHO) Oslo.Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology Oslo 2005.www.whocc.no"},{"key":"e_1_2_1_11_2","unstructured":"ApoteketAB.Svensk L\u00e4kemedelsstatistik (Swedish Drug statistics).2005. Sales of medicines in Sweden. Swedish National Corporation of Pharmacies.www.apoteket.se"},{"issue":"683","key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.0954-6820.1984.tb08709.x","article-title":"Measurement of drug utilization in Sweden: methodological and clinical implications","volume":"105","author":"Bergman U","year":"1984","journal-title":"Acta Medica Scandinavia"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.00197.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.624"},{"key":"e_1_2_1_15_2","first-page":"5472","article-title":"Har vi r\u00e5d med en bra kolesterols\u00e4nkande behandling? Budgetunderlag f\u00f6r behovsbaserade statinkostnader i Stockholms l\u00e4n [Can we afford good cholesterol lowering therapy? Budgeting of statin costs versus medical needs in the county of Stockholm]","volume":"98","author":"Wettermark B","year":"2001","journal-title":"L\u00e4kartidningen"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1154"},{"key":"e_1_2_1_17_2","unstructured":"Haaijer\u2010RuskampFM HovenJL MolPGM.A conceptual framework for constructing prescribing quality indicators: a proposal. DURQUIM: drug utilization quality indicator meeting. Mechelen Belgium WHO Europe.2004."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.88.3.229"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.18.1458"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02355.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00192.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050360"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00388-2"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2005.01.010"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.580"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1375\/1369052012155"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.1992.tb01306.x"},{"key":"e_1_2_1_28_2","unstructured":"World Health Organization (WHO).Adherence to Long\u2010term therapies: evidence for action.2003."},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.3.337"},{"key":"e_1_2_1_30_2","unstructured":"Sundstr\u00f6mA JanssonK WiholmBE.The CCNET Control\u2010Pool: a database of 2000 randomly selected community controls in Sweden. Abstract presented at the \u20188th Annual Meeting\u2014European Society of Pharmacovigilance\u2019 Verona September2000. Conference\u2010book edited by Giampaolo Velo and Roberto Leone (Elsevier)."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16261-2"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1082"},{"key":"e_1_2_1_33_2","unstructured":"Swedish Health Data Registers Act(1998:543)."},{"key":"e_1_2_1_34_2","unstructured":"International Society of Pharmacoepidemiology (ISPE).Guidelines for Good Practice in Data Privacy Medical Record Confidentiality and Research in the interest of Public Health.http:\/\/www.pharmacoepi.org\/resources\/privacy.cfm"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.627"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7451.1300"},{"key":"e_1_2_1_37_2","first-page":"19","article-title":"The Finnish database on drug utilisation","volume":"11","author":"Klaukka T","year":"2001","journal-title":"Norwegian Journal of Epidemiology"},{"issue":"1","key":"e_1_2_1_38_2","first-page":"53","article-title":"Reseptbasert legemiddelregister: Et viktig verkt\u00f8y for \u00e5 oppn\u00e5 detaljert legemiddelstatistikk","volume":"14","author":"Str\u00f8m H","year":"2004","journal-title":"(Article in Norwegian) Norsk Epidemiologi"},{"key":"e_1_2_1_39_2","first-page":"445","article-title":"The Danish prescription registries","volume":"44","author":"Gaist D","year":"1997","journal-title":"Dan Med Bull"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.1294","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.1294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T13:54:51Z","timestamp":1700056491000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.1294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,9]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1002\/pds.1294"],"URL":"https:\/\/doi.org\/10.1002\/pds.1294","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,9]]}}}